The purpose of the Clinical Research Core is to facilitate investigations of HIV infection and disease pathogenesis that require the use of human specimens. The Clinical Research Core builds upon the success of the previous CFAR Pediatric HIV Specimen Core by expanding the scope of operations to include infrastructure for acquisition of adult AIDS clinical specimens. Dr. William T. Shearer will be Core Director and Dr. Howard M. Rosenblatt (previous Director of the Pediatric Specimen Core) will be Assistant Director. New to this core is the installation of an adult ACTG subunit site at Baylor College of Medicine by Dr. Richard Pollard, Principal Investigator of the ACTG site at the University of Texas Medical Branch in Galveston. Up to 100 adult patients will be enrolled in the BCM ACTG subsite in the first year of operation. The newly funded General Clinical Research Center at The Methodist Hospital, Baylor's principal adult teaching hospital, will be able to enroll these patients into multicenter ACTG clinical protocols and obtain specimens. Also, as additional sources, the Thomas Street Clinic, the VA Hospital, and the Montrose Clinic will provide adult HIV specimens to basic researchers through the facilities of the CFAR Clinical Research Core. Creation of this core was prompted by the CFAR experience of the past 4 years and by the needs assessment performed during the pla:ning process for the CFAR renewal. This core will continue to supply pediatric HW specimens to basic researchers at Baylor and in other research institutions. Addition of the adult patient component to the Baylor CFAR greatly expands its ability to support basic and clinical HIV research and, eventually, patient care.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036211-07
Application #
6355556
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
7
Fiscal Year
2000
Total Cost
$108,748
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Tan, Qiumin; Brunetti, Lorenzo; Rousseaux, Maxime W C et al. (2018) Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma. Proc Natl Acad Sci U S A 115:E1511-E1519
Bayrer, James R; Wang, Hongtao; Nattiv, Roy et al. (2018) LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun 9:4055
Bui, Thanh Cong; Scheurer, Michael E; Pham, Vy Thi-Tuong et al. (2018) Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia. J Med Virol 90:1765-1774
Kim, Myunghoo; Galan, Carolina; Hill, Andrea A et al. (2018) Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses. Immunity 49:151-163.e5
Martini-Stoica, Heidi; Cole, Allysa L; Swartzlander, Daniel B et al. (2018) TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading. J Exp Med 215:2355-2377
Kogiso, Mari; Qi, Lin; Braun, Frank K et al. (2018) Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models. Clin Cancer Res 24:2159-2170
Xiao, Yangyan; de Paiva, Cintia S; Yu, Zhiyuan et al. (2018) Goblet cell-produced retinoic acid suppresses CD86 expression and IL-12 production in bone marrow-derived cells. Int Immunol 30:457-470
Yosef, Nejla; Vadakkan, Tegy J; Park, June-Hee et al. (2018) The phenotypic and functional properties of mouse yolk-sac-derived embryonic macrophages. Dev Biol 442:138-154
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Grzeskowiak, Caitlin L; Kundu, Samrat T; Mo, Xiulei et al. (2018) In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat Commun 9:2732

Showing the most recent 10 out of 690 publications